WEBULL
WebtradeDownload

Kerry Group (ISE:KRZ) Stock Premium Rides On Growth While Margins Ease

Simply Wall St · 2d ago

The Kerry Group share price has been grinding higher in recent months and closed at €84.55 ahead of the latest numbers. Today's reaction is really a referendum on one thing: the market is trying to decide whether a food ingredients group trading on a 21x P/E deserves that kind of premium when net profit margins sit at 9.6% after easing from 10.1% last year.

On the face of it the headline is solid. Adjusted earnings per share for the first half grew in the high single digits in constant currency and management kept full year adjusted EPS guidance intact. The question now is whether that combination of resilient growth and slightly softer margins justifies the current mood in the stock.

Love the steady earnings progress at Kerry Group but unsure about paying a premium P/E for softer margins? Benchmark it against a curated list of list of solid balance sheet and fundamentals stocks (421 results).

H1 2026 Earnings Summary

  • Revenue H1 2026: €3,336.4m vs. H1 2025 €3,463.1m (softer top line)
  • Net Income H1 2026: €282.6m vs. H1 2025 €303.1m (lower profit year on year)
  • Basic EPS H1 2026: €1.76 vs. H1 2025 €1.83 (EPS edged down)
  • Net Profit Margin Last 12 Months: 9.6% vs. prior year 10.1% (margin compression)

Prefer clean, visual charts instead of another dense block of earnings commentary and ratios? See Kerry Group's valuation picture at a glance in the interactive company report for Kerry Group.

ISE:KRZ Trailing 12-Month Revenue & Expenses Breakdown as at Jul 2026
ISE:KRZ Trailing 12-Month Revenue & Expenses Breakdown as at Jul 2026

Kerry Group’s Growth Story Meets Margin Reality

Bulls argue that Kerry Group can pair steady volume growth with margin expansion as higher value nutrition and biotech offerings scale. The first half goes some way to backing that up. Volumes grew 3.3% with Q2 improving to 3.5%, and emerging markets hit close to 5%. That supports the idea of outgrowing underlying food markets rather than just relying on pricing.

The margin piece is also moving in the right direction, which is central to the bullish view. EBITDA of €558m came with a 60 bps margin uplift, and management attributes 40 bps of that to the Accelerate 2.0 program. That is a clear milestone for the cost and footprint thesis. APMEA and Europe margins each expanded by 80 bps, which supports the case that new capacity, biotech and health focused lines can support a richer mix rather than just extra volume.

Compare Kerry Group’s internal margin uplift story with the external view and see whether analysts think this premium P/E still stacks up by checking the consensus price target analysis for Kerry Group.

Bear Case on Kerry Group Margins Faces Mixed Scorecard

The bearish view argues that Kerry Group will struggle to convert its cost programs and capacity builds into cleaner margins and cash, especially as new sites and digital projects ramp. The latest half year partly undercuts that. EBITDA margin expanded 60 bps with around two thirds tied to Accelerate 2.0 and mix, which shows the cost agenda is not purely theoretical. Volume growth of 3.3% with emerging markets near 5% also challenges fears that higher value platforms would stall in customer reformulation cycles.

However, several milestones are still missing. Net profit margin sits at 9.6%, lower than the prior 10.1%. Working capital absorbed about €81m as inventories were built, so cash conversion at 76% lags management’s own 85% reference point. Non trading items of €32m linked to Accelerate 2.0 underline that execution risk and cash costs remain live, even as management keeps full year EPS guidance unchanged.

With earnings slipping 1% per year and margins easing to 9.6%, are Kerry Group’s cash flows, debt and liquidity aligned with that 21x P/E, or stretched thin? Verify the full picture in our financial health analysis of Kerry Group stock.

Stay Ahead With Simply Wall St

If the premium 21x P/E against a 9.6% net profit margin has put Kerry Group on your radar, register for free with Simply Wall St and add it to your Watchlist to track share price against fair value and watch for a more attractive entry point. Once you own it or any other stock, use the Portfolio Command Center to cut through noise and focus on the updates that really affect your holdings. For a longer term view, tap into thousands of investor opinions and discussion threads through the Community to see how others are thinking about similar risks and opportunities. This combination helps you spot potential catalysts and warning signs early so you can stay ahead of the market instead of reacting late.

Curious About Alternatives To Kerry Group

The best opportunities often move first. New themes can start to break out, gain momentum and get caught by the crowd fast. Scan fresh ideas while it matters and get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.